Aquinox Pharmaceuticals (Canada) Inc.

Canada

 
Total IP 10
Total IP Rank # 153,499
IP Activity Score 0/5.0    0
IP Activity Rank # 1,660,322

Patents

Trademarks

0 0
0 0
10 0
0
 
Last Patent 2019 - Hexadecahydro-1h-cyclopenta[a]ph...
First Patent 2004 - Indene derivatives as pharmaceut...

Latest Inventions, Goods, Services

2019 Invention Hexadecahydro-1h-cyclopenta[a]phenanthrene derivatives useful in treating pain and inflammation. ...
Invention Indene derivatives useful in treating pain and inflammation. Compounds of formula (I) wherein, R1...
Invention Indene derivatives useful in treating pain and inflammation. Compounds of formula (I): wherein,R1...
2018 Invention Ship1 modulators and methods related thereto. Compounds of formula (I): Compounds of formula (...
Invention Crystalline solid forms of the acetate salt of (1s,3s,4r)-4-((3as,4r,5s,7as)-4-(aminomethyl)-7a-m...
2017 Invention Crystalline solid forms of (1s,3s,4r)-4-((3as,4r,5s,7as)-4- (aminomethyl)-7a-methyl-1-methyleneoc...
Invention Ship1 activator for treating prostatitis. This invention is directed to the use of a SHIP1 activa...
Invention Methods of treating prostatitis. This invention is directed to the use of a SHIP1 activator, pre...
Invention Synthesis of a substituted indene derivative. This invention is directed to methods of preparing ...
2014 Invention Ship1 modulators and methods related thereto. Compounds of formula (II): wherein A, R1, R2, R5 an...
Invention Ship1 modulators and methods related thereto. Compounds of formula (I): where R1, R2, R3, R4a, R4...
Invention Indene derivatives as pharmaceutical agents. Processes for making and using compounds of formula...
Invention Ship1 modulators and methods related thereto. Compounds of formula (I): [Formula should be insert...
2010 Invention Ship1 modulators and methods related thereto. Compounds of structure (I): including stereoisomers...
2009 Invention Indene derivatives as pharmaceutical agents. Compounds of formula (Ia): 6 are defined herein, as...
2004 Invention Indene derivatives as pharmaceutical agents. Compounds of formula (Ia): wherein R1, R2, R3, R4a, ...